A case-control study to evaluate urinary tract complications in radical hysterectomy.
BACKGROUND: This study has evaluated urinary tract injuries and dysfunction after Radical Hysterectomy (RH) performed in patients with cervical cancer and has compared the cystometric parameters and urinary complications occurring in these patients with those occurring in patients who had undergone Simple Hysterectomy (SH). PATIENTS AND METHODS: A prospective case-control study was conducted to evaluate urinary tract injuries (intra-operative and post-operative) and dysfunction in 50 patients undergoing RH for cervical cancer and to compare them with the same parameters in 50 patients who underwent SH for benign disease. RESULTS: Mean age in the RH group was 46.3 years and in the SH group was 50.1 (p = 0.63). There were no bladder and urethral injuries in either group of patients. There was one intra-operative ureteral injury in the RH patients but none in those who underwent SH. (p < 0.05). In the two weeks after surgery, 15% of RH patients and 11% of SH patients had experienced a urinary tract infection urinary tract infection (p = 0.61). Two week after surgery 62% of RH patients had no urinary symptoms, compared to 84% in the SH group who did (p < 0.02). Urinary residual volume, first urinary sensation and maximal bladder capacity were higher in the RH group, but this was not statistically significant. The only case of a urinary fistula appeared in a patient who received 5000 cGy radiation therapy pre-operatively, but this spontaneously healed after 3 weeks of catheterization. CONCLUSIONS: Intra-operative and post-operative urinary tract complications are comparable in patients undergoing RH and SH and an expert gynaecological oncologist might be able to further decrease complications. However, radiation therapy before surgery may increase the risk of complications.
Behtash
Nadereh
N
Department of Gynaecology Oncology, Tehran University of Medical Sciences, Tehran, Iran. nadbehtash@yahoo.com.
Ghaemmaghami
Fatemeh
F
Ayatollahi
Haleh
H
Khaledi
Hediyeh
H
Hanjani
Parviz
P
Eur J Gynaecol Oncol. 1991;12(1):27-30
2050156
Acta Obstet Gynecol Scand. 1989;68(4):331-40
2618621
Crit Rev Oncol Hematol. 2003 Dec;48(3):287-93
14693341
Minerva Ginecol. 1993 Dec;45(12):591-6
8139784
Scand J Urol Nephrol. 1970;4(2):107-16
5518084
Braz J Med Biol Res. 1997 Jan;30(1):29-33
9222400
Am J Obstet Gynecol. 2003 Aug;189(2):380-3; discussion 383-4
14520200
Obstet Gynecol. 1986 Jul;68(1):111-20
3725241
Gynecol Oncol. 2002 Jan;84(1):36-42
11748973
Recenti Prog Med. 2003 Dec;94(12):562-7
14974153
Eur J Cancer. 2004 Feb;40(3):375-8
14746855
Gynecol Oncol. 2002 May;85(2):292-7
11972390
Urology. 1986 Dec;28(6):462-8
3787918
Int J Urol. 1997 May;4(3):259-64
9255663
Br J Obstet Gynaecol. 1983 Sep;90(9):858-63
6615743
Br J Cancer. 2001 Dec 14;85(12):1824-30
11747321